Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2015

These securities consist of the following (in thousands):

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2015	2014	2015	2014
Outstanding stock options	20,138	17,417	20,138	17,417
Warrant to purchase common stock	200	200	200	200
Purchase Plan	223	199	144	131


	20,561	17,816	20,482	17,748